ALIM - Alimera Sciences, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
50,368
46,970
35,912
34,333
22,438
Cost of Revenue
5,436
4,679
3,438
2,344
1,762
Gross Profit
44,932
42,291
32,474
31,989
20,676
Operating Expenses
Research Development
11,236
11,274
12,844
12,375
14,840
Selling General and Administrative
38,152
38,042
36,249
44,694
42,280
Total Operating Expenses
52,040
51,961
51,777
59,836
59,675
Operating Income or Loss
-7,108
-9,670
-19,303
-27,847
-38,999
Interest Expense
4,910
4,776
5,579
5,178
4,693
Total Other Income/Expenses Net
-119
-1,831
3,044
23
13,177
Income Before Tax
-12,137
-16,277
-21,838
-33,002
-30,515
Income Tax Expense
362
106
163
172
130
Income from Continuing Operations
-12,499
-16,383
-22,001
-33,174
-30,645
Net Income
-12,499
-16,383
-22,001
-33,174
-30,645
Net Income available to common shareholders
25,831
21,947
-22,001
-33,174
-30,645
Reported EPS
Basic
-
0.25
-0.33
-0.63
-0.69
Diluted
-
0.25
-0.33
-0.63
-0.69
Weighted average shares outstanding
Basic
-
70,003
66,994
52,802
44,450
Diluted
-
70,738
66,994
52,802
44,450
EBITDA
-
-8,856
-13,575
-25,057
-23,267